# Amsterdam Investigator-initiateD Absorb Strategy All-comers Trial

> **NCT01858077** · NA · UNKNOWN · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 1845 (actual)

## Conditions studied

- Coronary Artery Disease
- Myocardial Infarction

## Interventions

- **DEVICE:** ABSORB BVS™
- **DEVICE:** XIENCE™

## Key facts

- **NCT ID:** NCT01858077
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-08
- **Primary completion:** 2017-12
- **Final completion:** 2020-12
- **Target enrollment:** 1845 (ACTUAL)
- **Last updated:** 2019-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01858077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01858077, "Amsterdam Investigator-initiateD Absorb Strategy All-comers Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01858077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*